Related Experiment Video
Updated: Jan 24, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Statins significantly reduce mortality in patients receiving clopidogrel without affecting platelet activation and
Ke An1,2, Rong Huang1, Sai Tian1
1Department of Endocrinology, Affiliated Zhongda Hospital of Southeast University, No. 87 DingJiaQiao Road, Nanjing, 210009, People's Republic of China.
Insights
Statins reduce mortality in patients taking clopidogrel without impacting platelet activation or aggregation. This combination therapy is safe and effective for coronary artery disease patients.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Coronary artery disease (CAD) patients frequently receive combination therapy with statins and clopidogrel.
- Both medications are primarily metabolized by cytochrome P450 isoenzyme 3A4 (CYP3A4) in the liver.
- Potential drug interactions affecting efficacy necessitate investigation.
Purpose of the Study:
- To evaluate the impact of co-administering statins with clopidogrel on their respective efficacies.
- To determine if statins influence clopidogrel's antiplatelet effects or patient mortality.
Main Methods:
- A systematic search of major databases (PubMed, Embase, Cochrane, Web of Science) and ClinicalTrials.gov was conducted.
- Included studies comprised randomized controlled trials (RCTs) and cohort studies, assessed for quality.
- Data were pooled using random-effects models to calculate standard mean differences (SMD) and risk ratios (RR) with 95% confidence intervals (CI).
Main Results:
- Twenty-eight studies with 25,267 participants were analyzed.
- Statins significantly reduced mortality in patients on clopidogrel (RR 0.54; 95% CI 0.40-0.74).
- No significant differences were observed in platelet aggregation, P-selectin, CD40L, CD63, or PAC-1 expression. Triglyceride levels were affected by statin metabolism type.
Conclusions:
- Combination therapy of statins and clopidogrel is confirmed to reduce mortality in CAD patients.
- Statins do not adversely affect clopidogrel's antiplatelet activation or aggregation properties.
- The findings support the continued use of this combination therapy for cardiovascular risk reduction.
Background:
Combination of statins and clopidogrel is frequently administered in patients with coronary artery disease (CAD). They are mainly activated and eliminated in the liver by cytochrome P450 isoenzyme 3A4 (CYP3A4). The aim was to clarify whether the coadministration of clopidogrel and statins attenuate respective efficacy.
Methods:
PubMed, Embase, the Cochrane Library, Web of Science and Clinical Trials. gov were searched for until August 2018. Randomized controlled trials (RCTs) and cohort studies were taken into quality evaluation. Data were pooled using random effect models to estimate standard mean difference (SMD) or risk ratio (RR) with 95% confidence interval (CI).
Results:
In total, 28 studies representing 25,267 participants were included. Statins reduce the mortality of patients administered clopidogrel (RR 0.54; 95% CI 0.40,0.74; p = 0.000), no differences were found in platelet aggregation (PA) (SMD 0.02; 95% CI -0.38,0.42; p = 0.920) and the expressions of P-selectin (SMD -0.04; 95% CI -0.14,0.05; p = 0.346), CD40L (SMD 0.09; 95% CI -0.29,0.48; p = 0.633), CD63 (SMD 0.09; 95% CI -0.01,0.19; p = 0.079) and PAC-1 (SMD 0.03; 95% CI -0.08,0.13; p = 0.633). Furthermore, CYP3A4 metabolized or non-CYP3A4 metabolized statins have no discrepancies in PA (SMD 0.13; 95% CI -0.31,0.58; p = 0.556), P-selectin (SMD 0.17; 95% CI -0.16,0.51; p = 0310), death (RR 0.89; 95% CI 0.38,2.07; p = 0.791), except for triglyceride (TG) (SMD -0.19; 95% CI -0.33,-0.06; p = 0.005).
Conclusions:
This meta-analysis confirmed that statins reduce mortality in patients undergoing clopidogrel treatment without affecting platelet activation and aggregation.
More Related Videos
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Receiver Operating Characteristic Plot
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups